These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2912669)
1. Calculation of heparin dosage in a morbidly obese woman. Ellison MJ; Sawyer WT; Mills TC Clin Pharm; 1989 Jan; 8(1):65-8. PubMed ID: 2912669 [No Abstract] [Full Text] [Related]
2. Comparative dosage and toxicity of heparin sodium in the treatment of patients with pulmonary embolism versus deep-vein thrombosis. Tenero DM; Bell HE; Deitz PA; Bertino JS Clin Pharm; 1989 Jan; 8(1):40-3. PubMed ID: 2912663 [No Abstract] [Full Text] [Related]
3. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins? Agnelli G Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776 [No Abstract] [Full Text] [Related]
4. Should heparin be managed with a nomogram? Vine DL Kans Med; 1992 Dec; 93(12):359, 360. PubMed ID: 1287287 [No Abstract] [Full Text] [Related]
5. Use of the subcutaneous heparin pump during pregnancy. Barss VA; Schwartz PA; Greene MF; Phillippe M; Saltzman D; Frigoletto FD J Reprod Med; 1985 Dec; 30(12):899-901. PubMed ID: 4078826 [TBL] [Abstract][Full Text] [Related]
6. Use of a modified dosing weight for heparin therapy in a morbidly obese patient. Schwiesow SJ; Wessell AM; Steyer TE Ann Pharmacother; 2005 Apr; 39(4):753-6. PubMed ID: 15741422 [TBL] [Abstract][Full Text] [Related]
7. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. Wheeler AP; Jaquiss RD; Newman JH Arch Intern Med; 1988 Jun; 148(6):1321-5. PubMed ID: 3377615 [TBL] [Abstract][Full Text] [Related]
8. Heparin therapy - Part II. Caprini JA; Zoellner JL; Weisman M Cardiovasc Nurs; 1977; 13(4):17-20. PubMed ID: 586158 [No Abstract] [Full Text] [Related]
9. [Long-term administration of heparin in a pregnant woman following pulmonary artery embolism]. Klawe Z; Uszyński L; Klawe Pol Tyg Lek; 1975 Nov; 30(45):1885-6. PubMed ID: 1187450 [No Abstract] [Full Text] [Related]
17. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. Basu D; Gallus A; Hirsh J; Cade J N Engl J Med; 1972 Aug; 287(7):324-7. PubMed ID: 5041701 [No Abstract] [Full Text] [Related]
18. Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity. Barletta JF; DeYoung JL; McAllen K; Baker R; Pendleton K Surg Obes Relat Dis; 2008; 4(6):748-53. PubMed ID: 18586569 [TBL] [Abstract][Full Text] [Related]